(1) Effective February 17, 1998, the Michigan biologic products institute, established by Executive Order 1995-25, is transferred to the Michigan department of community health as a type I transfer. As used in this subsection, “type I transfer” means that term as defined in section 3 of the executive organization act of 1965, 1965 PA 380, MCL 16.103.
  (2) The institute is an independent and autonomous entity. The institute and the director of the institute shall exercise the powers and perform the duties prescribed by this act independently of the principal executive departments of this state, including, but not limited to, personnel, budgeting, procurement, and management-related functions.

Terms Used In Michigan Laws 333.26333a

  • Institute: means the Michigan biologic products institute established by Executive Order 1995-25, pursuant to section 4 of article V of the state constitution of 1963, and by section 3a. See Michigan Laws 333.26333
  • state: when applied to the different parts of the United States, shall be construed to extend to and include the District of Columbia and the several territories belonging to the United States; and the words "United States" shall be construed to include the district and territories. See Michigan Laws 8.3o
  (3) The governor shall appoint a director for the institute, who shall be the head of the institute, within the meaning of the executive organization act of 1965, 1965 PA 380, MCL 16.101 to 16.608. The director is also the appointing authority for purposes of section 5 of article XI of the state constitution of 1963.
  (4) The institute has the powers, duties, and responsibilities prescribed in Executive Order 1995-25, and shall operate pursuant to and in accordance with Executive Order 1995-25.